Skip to main content
. 2022 May 16;11(10):e023038. doi: 10.1161/JAHA.121.023038

Table 1.

Characteristics of the 764 Diabetes‐Free Adults in the ORIGINS Study

Characteristic Mean (SD) or n (%) ≤ Median CMZ > Median CMZ P value
Age, y 31.66 (9.36) 29.30 (7.96) 34.03 (10.06) <0.0001
Sex <0.0001
Women 541 (70.81%) 305 (79.84%) 236 (61.78%)
Men 223 (29.19%) 77 (20.16%) 146 (38.22%)
Race and ethnicity <0.0001
Hispanic 217 (28.40%) 146 (38.22%) 71 (18.59%)
Non‐Hispanic White 111 (14.53%) 30 (7.85%) 81 (21.20%)
Black 212 (27.75%) 89 (23.30%) 123 (32.20%)
Other (including American Indian/Alaska Native, Native Hawaiian/Pacific Islander, and Asian) 218 (28.53%) 113 (29.58%) 105 (27.49%)
Education <0.0001
< Bachelor’s degree 171 (22.38%) 52 (13.61%) 119 (31.15%)
Bachelor’s degree 365 (47.77%) 204 (53.40%) 161 (42.15%)
> Bachelor’s degree 204 (26.70%) 115 (30.10%) 89 (23.30%)
Smoking status 0.82
Never 630 (82.46%) 315 (82.46%) 315 (82.46%)
Former 43 (5.63%) 23 (6.02%) 20 (5.24%)
Current 49 (6.41%) 23 (6.02%) 26 (6.81%)
BMI, kg/m2 25.52 (5.81) 22.91 (3.77) 28.14 (6.29) <0.0001
Periodontal disease <0.0001
None/mild 540 (70.68%) 294 (76.96%) 246 (64.40%)
Moderate/severe 217 (28.40%) 87 (22.77%) 130 (34.04%)
Bacterial gene abundance summary scores
RD pathway* 0.033 (0.008) 0.034 (0.008) 0.033 (0.008) 0.01
ANR pathway* 0.017 (0.005) 0.017 (0.005) 0.017 (0.005) 0.54
DNRA pathway* 0.020 (0.005) 0.020 (0.005) 0.020 (0.005) 0.37
NO2 product* 0.031 (0.006) 0.031 (0.006) 0.030 (0.007) 0.02
NO product* 0.018 (0.004) 0.018 (0.004) 0.017 (0.005) 0.01
NH3 product* 0.025 (0.004) 0.025 (0.004) 0.025 (0.004) 0.78
Ratios of nitrite generation‐to‐depletion gene abundances
RD vs ANR ratio 4.18 (2.19) 4.37 (2.35) 4.00 (2.01) 0.02
RD vs DNRA ratio 3.99 (5.11) 4.26 (5.83) 3.72 (4.26) 0.14
RD vs ANR+DNRA ratio 1.65 (0.87) 1.72 (0.89) 1.58 (0.85) 0.02
NO2 vs NH3 ratio 1.66 (0.72) 1.72 (0.74) 1.61 (0.70) 0.03
NO vs NH3 ratio 0.57 (0.30) 0.6 (0.30) 0.55 (0.30) 0.01
NO+NO2 vs NH3 ratio 2.23 (0.99) 2.32 (1.01) 2.15 (0.96) 0.02
NO2 vs NO+NH3 ratio 1.02 (0.27) 1.04 (0.27) 1.01 (0.28) 0.06
Cardiometabolic risk biomarkers
Insulin 7.68 (4.62) 5.10 (1.96) 10.26 (5.06) <0.0001
HOMA‐IR 1.64 (1.09) 1.02 (0.40) 2.26 (1.19) <0.0001
HbA1C 5.26 (0.33) 5.12 (0.27) 5.40 (0.32) <0.0001
Fasting plasma glucose 84.78 (8.22) 80.70 (5.45) 88.87 (8.48) <0.0001
Diastolic blood pressure 72.29 (9.05) 67.20 (6.54) 77.39 (8.33) <0.0001
Systolic blood pressure 116.70 (12.28) 110.18 (8.90) 123.23 (11.71) <0.0001

Values are presented as mean (SD) or n (%). P values are for ANOVA F statistics or χ2 tests for differences in level of covariates between participants with less than median CMZ score and more than median CMZ score. Missing values: n=6 for race and ethnicity, n=24 for education, n=42 for smoking status, n=11 for BMI, n=7 for periodontal status. ANR indicates assimilatory nitrate reduction; BMI, body mass index; CMZ, composite cardiometabolic score that averages the Z scores for the individual cardiometabolic risk variables; DNRA, dissimilatory nitrate reduction to ammonia; HbA1c, hemoglobin A1c; HOMA‐IR, Homeostatic Model Assessment of Insulin Resistance; NH3, ammonia; NO, nitric oxide; NO2, nitrite; ORIGINS, Oral Infections, Glucose Intolerance, and Insulin Resistance Study and RD, respiratory denitrification.

*

Arcsine square root transformed summary scores of relative gene abundance.

Ratios of nitrite generation‐to‐depletion proportions of pathway and product relative gene abundances before log‐transformation.